// App-Quantinova.ai

P341 : A NOVEL BISPECIFIC T CELL ENGAGER (UMG2-CD3) IS EFFECTIVE AGAINST CORTICAL-DERIVED ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Caterina Riillo

Principal Investigators

  • Daniele Caracciolo

  • Katia Grillone

  • Franca Maria Tuccillo

  • Giada Juli

  • Francesca Scionti

  • Mariamena Arbitrio

  • Maria Anna Siciliano

  • Simona Sestito

  • Marco Rossi

  • Andrea Ballerini

  • Massimo Gentile

  • Maria Teresa Di Martino

  • Pierosandro Tagliaferri

  • Pierfrancesco Tassone

Medical Centers

  • Institute of Research and Biomedical Innovation (IRIB), Italian National Council (CNR),Messina,Italien

  • Clinical and Experimental Medicine,Università Magna Graecia,Catanzaro,Italie

  • Clinical and Experimental Medicine,Università Magna Graecia,Catanzaro,Italie

  • biovelocITA srl,Milano,Italia

  • Pugliese-Ciaccio Hospital, Catanzaro, Italy

  • Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS,Napoli,Itália

  • Annunziata Hospital,Cosenza,Italië

  • Annunziata Hospital,Cosenza,Italië

  • Clinical

  • Pugliese-Ciaccio Hospital, Catanzaro, Italy

  • biovelocITA srl,Milano,Italia

  • Università Magna Graecia,Catanzaro,Италия

  • Istituto Nazionale Tumori " Fondazione

  • Annunziata Hospital,Cosenza,Italië

  • biovelocITA srl,Milano,Italia

  • Clinical and Experimental Medicine,Università Magna Graecia,Catanzaro,Italie

  • Annunziata Hospital,Cosenza,Italië

  • Clinical and Ex

  • biovelocITA srl,Milano,Italia

  • Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS,Napoli,Itália

  • Università Magna Graecia,Catanzaro,Italien

  • Institute of Research and Biomedical Innovation (IRIB), Italian National Council (CNR),Messina,Italien

  • Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS,Napoli,Itália

  • Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS,Napoli,Itália

  • Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS,Napoli,Itália

  • Università Magna Graecia,Catanzaro,Italien

  • Universita della Magna Graecia, Catanzaro, Italy.

  • Pugliese-Ciaccio Hospital, Catanzaro, Italy

  • Pugliese-Ciaccio Hospital, Catanzaro, Italy

  • Pugliese-Ciaccio Hospital, Catanzaro, Italy

  • Clinical and Experimental Medicine,Università Magna Graecia,Catanzaro,Italie

  • Pugliele-Ciaccio Hospital ,Catanzaro,Италия

  • Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS,Napoli,Itália

  • Clinical and Experimental Medicine,Università Magna Graecia,Catanzaro,Italie

  • Clinical and Experimental Medicine,Università Magna Graecia,Catanzaro,Italie

  • Pugliese-Ciaccio Hospital, Catanzaro, Italy

  • Annunziata Hospital,Cosenza,Италия

  • Institute of Research and Biomedical Innovation (IRIB), Italian National Council (CNR),Messina,Italien

  • Istituto Nazionale Tumori 'Fondazione G.Pascale'-

  • Pugliese-Ciaccio Hospital, Catanzaro, Italy

  • Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS,Napoli,Itália

  • Pugliese-Ciaccio Hospital, Catanzaro, Italy

  • Clinical and Experimental Medicine,Università Magna Graecia,Catanzaro,Italie

  • Pugliele-Ciaccio Hospital ,Catanzaro,Италия

  • Clinical and Experimental Medicine,Università Magna Graecia,Catanzaro,Italie

  • Clinical and Experimental Medicine,Università Magna Graecia,Catanzaro,Italie

  • Clinical and Experimental Medicine,Università Magna Graecia,Catanzaro,Italie

  • biovelocITA srl,Milano,Italia

  • Annunziata Hospital,Cosenza,Italië

  • Università Magna Graecia,Catanzaro,Italien

  • Institute of Research and Biomedical Innovation (IRIB), Italian National Council (CNR),Messina,Italien

  • Annunziata Hospital,Cosenza,Italië

  • Pugliese-Ciaccio Hospital, Catanzaro, Italy

  • Institute of Research and Biomedical Innovation (IRIB), Italian National Council (CNR),Messina,Italien

  • Institute of Research and Biomedical Innovation (IRIB), Italian National Council (CNR),Messina,Italien

  • Pugliese-Ciaccio Hospital, Catanzaro, Italy

  • Clinical and Experimental Medicine,Università Magna Graecia,Catanzaro,Italie

  • Pugliese-Ciaccio Hospital, Catanzaro, Italy

  • Università Magna Graecia,Catanzaro,Italien

  • Institute of Research and Biomedical Innovation (IRIB), Italian National Council (CNR),Messina,Italien

  • Institute of Research and Biomedical Innovation (IRIB), Italian National Council (CNR),Messina,Italien

  • Università Magna Graecia,Catanzaro,Italien

  • Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS,Napoli,Itália

  • Clinical and Experimental Medicine,Università Magna Graecia,Catanzaro,Italie

  • biovelocITA srl,Milano,Италия

  • biovelocITA srl,Milano,Italia

  • Pugliese-Ciaccio Hospital, Catanzaro, Italy

Locations

  • Italy

  • South Africa

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Cluster of Differentiation 4

  • Cluster of Differentiation 56

  • Cluster of differentiation 8A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved